N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation
Top Cited Papers
- 3 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (18) , 1768-1774
- https://doi.org/10.1161/circulationaha.109.873265
Abstract
Background— Atrial fibrillation (AF), the most common cardiac rhythm abnormality, is associated with significant morbidity, mortality, and healthcare expenditures. Elevated B-type natriuretic peptide levels have been associated with the risk of heart failure, AF, and mortality. Methods and Results— The relation between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and AF was studied in 5445 Cardiovascular Health Study participants with the use of relative risk regression for predicting prevalent AF and Cox proportional hazards for predicting incident AF. NT-proBNP levels were strongly associated with prevalent AF, with an unadjusted prevalence ratio of 128 for the highest quintile (95% confidence interval, 17.9 to 913.3; P P P P Conclusions— In a community-based population of older adults, NT-proBNP was a remarkable predictor of incident AF, independent of any other previously described risk factor.Keywords
This publication has 26 references indexed in Scilit:
- Atrial Natriuretic Peptide Frameshift Mutation in Familial Atrial FibrillationNew England Journal of Medicine, 2008
- The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillationEuropean Heart Journal, 2006
- Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillationJournal of the American College of Cardiology, 2005
- Atrial natriuretic peptide modulates the hyperpolarization-activated current (If) in human atrial myocytesCardiovascular Research, 2004
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health StudyAnnals of Epidemiology, 1995
- Electrophysiological Effects of atrial Natriuretic Peptide on the Cardiac Conduction System in ManPacing and Clinical Electrophysiology, 1993
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991